$NRIX Cashflow Statement | Understand Stock

$NRIX

$25.55 +$0.21 (0.83%) Close

$NRIX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Nov 30, 2025	FY2024 12 months to Nov 30, 2024	FY2023 12 months to Nov 30, 2023	FY2022 12 months to Nov 30, 2022	FY2021 12 months to Nov 30, 2021
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Stock-based compensation
Net accretion of discount on marketable securities
Loss on disposal of property and equipment
Amortization of operating lease right-of-use assets
Other
Changes in operating assets and liabilities:
Contract assets
Accounts receivable
Income tax receivable
Prepaid expenses and other assets
Accounts payable
Deferred revenue
Operating lease liabilities
Accrued expenses and other current liabilities

Net cash used in operating activities
Cash flows from investing activities
Sales of marketable securities
Purchases of marketable securities
Maturities of marketable securities
Purchases of property and equipment
Net cash provided by (used in) investing activities

Cash flows from financing activities
Proceeds from issuances of common stock and pre-funded warrants, net of issuance costs
Proceeds from exercise of stock options and pre-funded warrants
Proceeds from issuance of common stock under employee stock purchase plan
Proceeds from issuances of common stock in "at the market" financing, net of issuance costs
Proceeds from exercise of stock options
Repurchase of unvested early exercised stock options
Net cash provided by financing activities

Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Cash paid for income taxes
Supplemental disclosures of non-cash investing and financing activities:
Additions to property and equipment included in accounts payable and accrued expenses and other current liabilities
Right-of-use assets recognized in exchange for lease obligations
Capitalized stock-based compensation related to internal-use software development
Issuance costs related to equity financing included in accrued expenses and other current liabilities
Deferred issuance costs included in accounts payable and accrued expenses and other current liabilities
Deferred issuance costs recognized related to the "at the market" financing
Vesting of early exercised stock options
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents
Restricted cash

Comments